+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Transforming Growth Factor Beta 2"

Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H2 2018 - Product Thumbnail Image

Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H2 2018

  • Drug Pipelines
  • October 2018
  • 50 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Transforming Growth Factor Beta 2 (TGF-β2) is a protein that plays a role in the regulation of cell growth and differentiation. In oncology, TGF-β2 is used to treat a variety of cancers, including breast, lung, and prostate cancer. It works by inhibiting the growth of cancer cells and inducing apoptosis, or programmed cell death. TGF-β2 is also used to reduce the risk of metastasis, or the spread of cancer cells to other parts of the body. In addition, it has been shown to reduce the side effects of chemotherapy and radiation therapy. Several companies are involved in the development and production of TGF-β2 for oncology drugs. These include Amgen, Merck, Pfizer, Novartis, and Bristol-Myers Squibb. Show Less Read more